Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
IMVT
IMVT News & Events
-
Add to Watchlist
Trade IMVT
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
IMVT News
Immunovant Q3 Earnings Beat Expectations with Strong Cash Position
Feb 06 2026
seekingalpha
Purcell & Lefkowitz Investigates Immunovant's Board Actions for Shareholder Breach
Jan 05 2026
PRnewswire
IMVT Options Trading Kicks Off in February 2026
Dec 19 2025
NASDAQ.COM
Should You Consider Buying Immunovant Stock Following Roivant Sciences' $350 Million Stake Increase?
Dec 18 2025
NASDAQ.COM
Immunovant (IMVT) Rises 14.0% Following $550 Million Equity Raise Backed by Roivant for IMVT-1402 - Is the Bullish Outlook Still Valid?
Dec 15 2025
Yahoo Finance
Roivant Indicates Significant Progress in Pipeline with Faster Timelines
Dec 11 2025
Benzinga
Immunovant Raises $550 Million to Support IMVT-1402 Launch for Graves' Disease
Dec 11 2025
Globenewswire
Immunovant Prices $550 Million Stock Offering to Support Graves' Disease Drug Launch
Dec 11 2025
Newsfilter
Show More News
IMVT Events
02/06 07:10
Immunovant Cash and Cash Equivalents Reach $994.5 Million
As of December 31, 2025, Immunovant's cash and cash equivalents totaled $994.5 million, providing runway for announced indications through the potential commercial launch of IMVT-1402 in GD
Show More Events
IMVT Monitor News
Immunovant Q3 Earnings Beat Expectations with Strong Cash Position
Feb 06 2026
Immunovant Inc raises $550 million for IMVT-1402 launch
Dec 11 2025
IMVT Earnings Analysis
No Data
People Also Watch
